Advanced Medical Solutions Grp PLC Director/PDMR Shareholding (1427V)

TIDMAMS

RNS Number : 1427V

Advanced Medical Solutions Grp PLC

04 April 2019

 
 
     4 April 2019 
 

Advanced Medical Solutions Group plc

("AMS", the "Company" or the "Group")

Director/PDMR and PCA Shareholding

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, announces that it was notified on 1 April 2019 that on the same day, Chris Meredith, who is a Director and PDMR, had sold 5,735 Ordinary Shares of 5p held on his behalf in the name of Platform Securities Nominees Limited ("CM's Nominee") at a price of 318p per Ordinary Share. AMS was also notified that on 1 April 2019 that on the same day, Chris Meredith's PCA had sold 4,850 Ordinary Shares of 5p held on their behalf in the name of Platform Securities Nominees Limited ("PCA's Nominee") at a price of 318p per Ordinary Share.

On the same day, Chris Meredith purchased 5,735 Ordinary Shares of 5p through an Individual Savings Account held in his name at a price of 318.25p per Ordinary Share. The Company was also informed that at the same time an Individual Savings Account held in the name of Chris Meredith's PCA purchased 4,850 Ordinary Shares of 5p at a price of 318.25p per Ordinary Share.

The number of shares, and the beneficial ownership of the shares, held by Chris Meredith and his PCA's remains unchanged. These transactions are part of normalised tax planning.

The transactions are summarised below:

 
 Director          Number         Price           Number of         Price paid       Number of          Price paid 
                    of Ordinary    per Ordinary   Ordinary           per Ordinary    Ordinary            per Ordinary 
                    Shares         Share          Shares             Share by        Shares purchased    Share by 
                    sold from      sold           purchased          an Individual   by an Individual    an Individual 
                    Nominee                       by an              Savings         Savings Account     Savings 
                                                  Individual         Account                             Account 
                                                  Savings Account 
 Chris Meredith    5,735          318p            5,735             318.25p          -                  - 
                  -------------  --------------  ----------------  ---------------  -----------------  --------------- 
 Chris Meredith    4,850          318p            -                 -                4,850              318.25p 
                  -------------  --------------  ----------------  ---------------  -----------------  --------------- 
 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1.   Details of the person discharging managerial responsibilities/person 
       closely associated 
 a)   Name: Chris Meredith 
     --------------------------------------------------------------------- 
 2.   Reason for the notification 
     --------------------------------------------------------------------- 
 a)   Position/status: Director/PDMR 
     --------------------------------------------------------------------- 
 b)   Initial notification/Amendment: Initial Notification 
     --------------------------------------------------------------------- 
 3.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     --------------------------------------------------------------------- 
 a)   Name: Advanced Medical Solutions Group plc 
     --------------------------------------------------------------------- 
 b)   LEI: 213800HJP6OWOSZI1L74 
     --------------------------------------------------------------------- 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions 
       have been conducted 
     --------------------------------------------------------------------- 
 a)   Description of the financial instrument, type of instrument: 
       Ordinary Shares of 5p 
       Identification code: GB0004536594 
     --------------------------------------------------------------------- 
 b)      Nature of the transactions: 
           *    Sale of 5,735 Ordinary Shares of 5p held in the name 
                of CM's Nominee 
 
 
           *    Purchase of 5,735 Ordinary Shares of 5p by an 
                Individual Savings Account held in the name of Chris 
                Meredith 
     --------------------------------------------------------------------- 
 c)   Price(s) and volume(s): 
       Sale of shares: Price(s)                       Volume(s) 
        Sale of shares from CM's 
         Nominee holding at 318p 
         per share                     5,735 
                                      ---------- 
        Purchase by an Individual 
         Savings Account at 318.25p 
         per share                     5,735 
                                      ---------- 
     --------------------------------------------------------------------- 
 d)   Aggregated information: (Relates to those shares sold 
       only) 
       Aggregated volume: 5,735 
       Aggregated price: 318p 
     --------------------------------------------------------------------- 
 e)   Date of the transaction: 01/04/2019 
     --------------------------------------------------------------------- 
 f)   Place of the transaction: London Stock Exchange, AIM 
       Market (XLON) 
     --------------------------------------------------------------------- 
 
 
 1.   Details of the person discharging managerial responsibilities/person 
       closely associated 
 a)   Name: Chris Meredith 
     --------------------------------------------------------------------- 
 2.   Reason for the notification 
     --------------------------------------------------------------------- 
 a)   Position/status: Director/PDMR 
     --------------------------------------------------------------------- 
 b)   Initial notification/Amendment: Initial Notification 
     --------------------------------------------------------------------- 
 3.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     --------------------------------------------------------------------- 
 a)   Name: Advanced Medical Solutions Group plc 
     --------------------------------------------------------------------- 
 b)   LEI: 213800HJP6OWOSZI1L74 
     --------------------------------------------------------------------- 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions 
       have been conducted 
     --------------------------------------------------------------------- 
 a)   Description of the financial instrument, type of instrument: 
       Ordinary Shares of 5p 
       Identification code: GB0004536594 
     --------------------------------------------------------------------- 
 b)      Nature of the transactions: 
           *    Sale of 4,850 Ordinary Shares of 5p held in the name 
                of the PCA's Nominee 
 
 
           *    Purchase of 4,850 Ordinary Shares of 5p into an 
                Individual Savings Account held in the name of Chris 
                Meredith's PCA 
     --------------------------------------------------------------------- 
 c)   Price(s) and volume(s): 
       Sale of shares: Price(s)                       Volume(s) 
        Sale of shares from PCA's 
         Nominee holding at 318p 
         per share                     4,850 
                                      ---------- 
        Purchase by an Individual 
         Savings Account at 318.25p 
         per share                     4,850 
                                      ---------- 
     --------------------------------------------------------------------- 
 d)   Aggregated information: (Relates to those shares sold 
       only) 
       Aggregated volume: 4,850 
       Aggregated price: 318p 
     --------------------------------------------------------------------- 
 e)   Date of the transaction: 01/04/2018 
     --------------------------------------------------------------------- 
 f)   Place of the transaction: London Stock Exchange, AIM 
       Market (XLON) 
     --------------------------------------------------------------------- 
 

- End -

For further information, please visit www.admedsol.com or contact:

 
 Advanced Medical Solutions Group plc                Tel: [phone] 
                                                                545508 
 Chris Meredith, Chief Executive Officer 
  Eddie Johnson, Chief Financial Officer 
 
 Consilium Strategic Communications               Tel: [phone] 
                                                                  5700 
 Mary-Jane Elliott / Matthew Neal / Nicholas   [e-mail] 
  Brown / Olivia Manser 
 
 Investec Bank PLC (NOMAD & Broker)               Tel: [phone] 
                                                                  5970 
 Daniel Adams / Gary Clarence / Patrick 
  Robb 
 

About Advanced Medical Solutions Group plc - see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical and wound care markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include tissue adhesives, sutures, biosurgical devices, internal sealants, silver alginates, alginates and foams, which it markets under its brands; LiquiBand(R), LiquiBand(R) Fix 8(TM), RESORBA(R) and ActivHeal(R) as well as supplying under white label.

AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 75 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Group has approximately 630 employees. For more information, please see www.admedsol.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHGCGDSXBGBGCS

(END) Dow Jones Newswires

April 04, 2019 05:16 ET (09:16 GMT)